Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis
Ivanova, L.A.
Problemy Tuberkuleza 3: 16-19
1994
ISSN/ISBN: 0032-9533 PMID: 7937662 Document Number: 435203
The paper provides the results of treatment of chronic pulmonary tuberculosis patients by using immunoactive drugs (thymalin and T-activin) and prednisolone, which has been performed by monitoring immunological parameters. The patients with fibrous and cavernous tuberculosis display a combination of antituberculous antibody hyperproduction and specific cell-mediated response inhibition. Immunological hormone therapy allows normalization of the immunological status (an increase in the count and functional activity of T-lymphocytes) and relative stabilization of the process with cessation of bacterial isolation in shorter periods than in the controls, which is favourable to the reduction in hospital treatment periods.